Return to Clinical Studies
Clinical Studies
By Name
- ANA773
- ANG1005
- ANG1005
- Anti-KIR
- AP23573 ( Deforolimus)
- AUY922
- AUY922+ Bortezomib
- Azacitidine (Vidaza)
- AZD4877
- Bevacizumab+R-CHOP
- BGT226
- BHQ880
- BQS481
- BSI-201
- C80405
- CBP 501
- CDX-110
- Clofarabine+ Cytarabine
- Cordycepin
- CP-751,871
- CP-751,871
- CP-751,871
- CPX-351
- Cytarabine+ Arsenic Trioxide
- Dasatinib
- Docetaxel/Radiation
- E2805
- E3805/CHAARTED
- E5202
- E5597
- Enzastaurin
- EPO906A (Patupilone)
- Fluphenazine
- GRN163L
- GS-9219
- GT-111
- HE3235
- HuMax-CD20
- Hyper-Acute Pancreatic Cancer Vaccine
- IMO-2055
- IMO-2055
- Larotaxel+ Cisplatin
- LBH589+ Trastuzumab
- LDE225
- MCS110
- MLN4924
- MLN8237
- MP470
- Nilotinib
- Non-Small Cell Lung Cancer
- NPI-2358
- Ofatumumab
- ONTAK
- PACCT-1
- Palifosfamide Tris
- Panobinostat
- PR11 (START)
- Pralatrexate
- Pralatrexate
- Pralatrexate
- Quarfloxin
- R7112
- R763
- RAD001 (Everolimus)
- RAD001
- Reolysin
- Reolysin+Paclitaxel+Carboplatin
- Romidepsin
- S0337
- S0421
- S0502
- SAHA+Hydroxychloroquine
- SCH 717454
- SCH727965
- SGI-1776
- STA-9090
- Stimuvax (L-BLP25)
- Tamibarotene
- Temsirolimus+ Sorafenib
- TH-302
- WT1-A10+AS01B
